IRMD
IRMD
US46266A1097
iRadimed Corporation
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.12B EUR
1.22B EUR
1.23B EUR
1.24B EUR
Enterprise Value
1.04B EUR
1.16B EUR
1.17B EUR
1.19B EUR
Valuation Multiples
Trailing P/E
48.85x
53x
52.12x
69.88x
Forward P/E
35.65x
--
--
--
Price to Sales
12.95x
14.15x
14.26x
19.34x
Price to Book
10.99x
12.01x
12.49x
13.14x
EV/Revenue
12.04x
13.47x
13.61x
18.54x
EV/EBITDA
35.6x
39.84x
39.96x
54.97x
Price to FCF (P/FCF)
69.04x
49.78x
51.33x
76.99x
EV/FCF
64.16x
47.37x
48.98x
73.82x
FCF Yield
1.45%
2.01%
1.95%
1.3%
ende